Prediction of time-integrated activity coefficients in PRRT using simulated dynamic PET and a pharmacokinetic model

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

Jean Claude Reubi, Jean-Claude Schär, Beatrice Waser et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2000 · 1.1K citations

Medicine, Nuclear Medicine, Radiology +15

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

Michael Gabriel, Clemens Decristoforo, Dorota Kendler et al. · Journal of Nuclear Medicine · 2007 · 1K citations · Full text

Medicine, Nuclear Medicine, Oncology +17

SAAM II: Simulation, analysis, and modeling software for tracer and pharmacokinetic studies

P. Hugh R. Barrett, Bradley M. Bell, Claudio Cobelli et al. · Metabolism · 1998 · 452 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +14

MIRD Pamphlet No. 23: Quantitative SPECT for Patient-Specific 3-Dimensional Dosimetry in Internal Radionuclide Therapy

Yuni K. Dewaraja, Eric C. Frey, George Sgouros et al. · Journal of Nuclear Medicine · 2012 · 407 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Quantitative and Qualitative Intrapatient Comparison of ⁶⁸Ga-DOTATOC and ⁶⁸Ga-DOTATATE: Net Uptake Rate for Accurate Quantification

Irina Velikyan, Anders Sundin, Jens Christian Hedemann Sørensen et al. · Journal of Nuclear Medicine · 2013 · 180 citations · Full text

Medicine, Nuclear Medicine, Oncology +17